![Donald Bergstrom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donald Bergstrom
Technik-/Wissenschafts-/F&E-Leiter bei
RELAY THERAPEUTICS, INC.
Vermögen: 6 Mio $ am 31.05.2026
Profil
Donald A. Bergstrom is currently an Independent Director at Cellectis SA since 2022, a Director at Cellectis, Inc., and President-Research & Development at Relay Therapeutics, Inc. since 2018.
Formerly, Dr. Bergstrom was an Independent Director at Fusion Pharmaceuticals, Inc. from 2021 to 2024, Chief Medical Officer & Senior Vice President at Mersana Therapeutics, Inc. from 2014 to 2018, Global Head-Translational & Experimental Medicine at Sanofi-Aventis U.S.
LLC from 2010 to 2014, Principal at Merck Research Laboratories Massachusetts LLC, and Global Head-Translational Medicine at Genzyme Therapeutics Ltd. from 2010 to 2014.
Education includes a doctorate from the University of Washington and an undergraduate degree from The Johns Hopkins University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RELAY THERAPEUTICS, INC. 0,22 % | 28.04.2026 | 418 557 ( 0,22 % ) | 6 Mio $ | 31.05.2026 |
Aktive Positionen von Donald Bergstrom
| Unternehmen | Position | Beginn |
|---|---|---|
| RELAY THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2018 |
| CELLECTIS S.A. | Direktor/Vorstandsmitglied | 28.06.2022 |
Cellectis, Inc.
 Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Donald Bergstrom
| Unternehmen | Position | Ende |
|---|---|---|
| FUSN PHAR | Direktor/Vorstandsmitglied | 04.06.2024 |
| MERSANA THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 31.03.2018 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Corporate Officer/Principal | 01.01.2014 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Corporate Officer/Principal | 01.01.2014 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | - |
Ausbildung von Donald Bergstrom
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
34
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Cellectis, Inc.
Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers | Health Technology |
Relay Therapeutics, Inc.
 Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
